News
Shortly after paying $800 million to take full control of BNT327, the biotech began a phase 3 trial to test the bispecific in combination with chemo in patients with previously untreated extensive ...
under multiple packages of the BharatNet Phase 3 program. ETTelecom reported on August 7, 2024, that the Telecommunications Consultants of India Limited (TCIL), ITI Limited, indigenous optical ...
Mural Oncology's stock plummeted 57% after halting the Phase 3 ARTISTRY-7 trial for nemvaleukin alfa, which failed to show significant overall survival benefits in PROC. The trial's failure delays ...
Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday. A total of 106 patients with ...
The Switch 2 will launch in June, and Nintendo will carry out the Switch 2's initial game release structure in a three-phase plan, sources tell Insider Gaming. Some of Nintendo's strategies for ...
MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage non ...
A major pet shop chain with 16 outlets in Northern Ireland has ended the sale of small animals following a year-long phase out, a move welcomed by a leading animal support charity. Jollyes ...
A confused parent turned to the internet to ask for help with their young child's homework after being left baffled by a take-home worksheet ... around matching a three letter word with the ...
A phase 3 trial will evaluate IMNN-001, the first immunotherapy to show an overall survival benefit in ovarian cancer. The FDA-aligned with a protocol to evaluate IMNN-001 with neoadjuvant ...
For more audio journalism and storytelling, download New York Times Audio, a new iOS app available for news subscribers. transcript This transcript was created using speech recognition software ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results